Men's Health

"When analyzing efficacy of minimally invasive/surgical therapies for lower urinary tract symptoms secondary to BPH, we appropriately focus on subjective criteria and objective criteria. While we discuss retreatment rates, we don’t measure failure of therapies by how many men restart LUTS/BPH medications," writes Steven A. Kaplan, MD.

Tissue-eliminating procedures outperform tissue-necrosing procedures for reducing the need for medication in patients with benign prostatic enlargement, researchers say.

Results of the prospective MedLift study establish the efficacy and safety of the Prostatic Urethral Lift (PUL [UroLift System]) procedure for treatment of symptomatic BPH in men with an enlarged median lobe.

In men undergoing prostate biopsy, use of prophylactic antibiotics has been increasing appropriately over time, and fluoroquinolones still dominate, results of an insurance claims database analysis show.

Performing green laser enucleation of the prostate with a live audience does not result in more complications, researchers say.

Men with large prostates experience more relief from BPH with treatment by Aquablation therapy (using the AquaBeam System) than with transurethral resection of the prostate, researchers say.

Studies show moderate alcohol intake has surprising links to prostate disease.

Christian Lawlor, BSc, Karl Miller, BSc, and David Albala, MD, explore the possible correlation.

A review of surgically acquired sperm for assisted reproductive technology and a multicenter study analyzing surgical sperm retrieval rates in men with non-mosaic Klinefelter’s syndrome undergoing micro-TESE were among other AUA 2018 take-homes in infertility/andrology.

The AUA 2018 take-home messages for BPH/LUTS also encompassed multiple treatment approaches for BPH as well as combination therapies for LUTS.

Urology visits afford a unique opportunity to discuss falls, drug use, and work accidents.

A 34-year-old male has a known left atrophic kidney. He has been suffering from recurrent bouts of prostatitis and ejaculatory pain radiating to his left flank. An MRI was obtained to evaluate the patient’s anatomy.

This article discusses the risk of depression and suicide in men, focusing on increased risk in men with genitourinary cancer and other urologic conditions.

To help you sift the enormous scientific program and prioritize your schedule at the AUA annual meeting, the editors have called upon Urology Times’ editorial advisory board to identify the key research across multiple areas of the specialty.

A 25-year-old male presents with 4 weeks of intermittent right flank pain occasionally radiating to the testicle. CT shows a 7-cm partially necrotic retroperitoneal mass at the level of the right renal vein and a 2-cm lesion overlaying the right psoas muscle.

Imaging reveals a mass at the anterior bladder dome with inflammation extending to the perivesical fat. No pelvic lymphadenopathy or sites of metastatic disease are found.

"As much as racial and ethnic disparities exist broadly across health care in the United States, it is not surprising to observe this phenomenon in the urologic arena," writes Arthur L. Burnett, II, MD, MBA.

In this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.

There are no national or international guidelines regarding penile transplants, raising a question without a concrete answer: What are the rules and the limits?

"[Penile transplantation] is a real advance for patients who have a penile deficiency or penile loss," says Arthur L. Burnett, II, MD, MBA.

These videos depict key steps of office-based approaches to hydrocelectomy and vasectomy reversal.

"There are direct endocrine consequences of opioid use, including hypogonadism, that adversely impact men’s health," write Michael S. Leapman, MD, and Steven A. Kaplan, MD.

The overall use of active surveillance in men with low-risk prostate cancer is 14.2%, according to an examination of the National Cancer Data Base.

Tissue-based prognostic biomarker assays for prostate cancer are not robust to tumor multifocality and heterogeneity, according to research presented at the American Society of Clinical Oncology annual meeting in Chicago.

Other pipeline products discussed in this round-up include and advanced renal cell carcinoma agent, a bladder cancer detection agent, and a BPH treatment.

It’s hard to argue against an erectile dysfunction treatment that is potentially disease modifying, is noninvasive, and seems to do no harm. The treatment, low-intensity shock wave therapy, has yet to earn the FDA’s approval but is widely used in other countries. Early results from ongoing U.S. trials are promising.

Other products and services discussed in this round-up include a biosimilar for cancer, an American College of Surgeons manual on quality initiatives, a kidney cancer microsite, and more.